BR112022012514A2 - Formas de dosagem sólidas que contêm bactérias e vesículas extracelulares microbianas - Google Patents
Formas de dosagem sólidas que contêm bactérias e vesículas extracelulares microbianasInfo
- Publication number
- BR112022012514A2 BR112022012514A2 BR112022012514A BR112022012514A BR112022012514A2 BR 112022012514 A2 BR112022012514 A2 BR 112022012514A2 BR 112022012514 A BR112022012514 A BR 112022012514A BR 112022012514 A BR112022012514 A BR 112022012514A BR 112022012514 A2 BR112022012514 A2 BR 112022012514A2
- Authority
- BR
- Brazil
- Prior art keywords
- dosage forms
- solid dosage
- extracellular vesicles
- forms containing
- containing bacteria
- Prior art date
Links
- 239000007909 solid dosage form Substances 0.000 title abstract 4
- 241000894006 Bacteria Species 0.000 title abstract 3
- 230000000813 microbial effect Effects 0.000 title abstract 3
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962954153P | 2019-12-27 | 2019-12-27 | |
| PCT/US2020/066828 WO2021133904A1 (en) | 2019-12-27 | 2020-12-23 | Solid dosage forms containing bacteria and microbial extracellular vesicles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022012514A2 true BR112022012514A2 (pt) | 2022-09-06 |
Family
ID=74626080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022012514A BR112022012514A2 (pt) | 2019-12-27 | 2020-12-23 | Formas de dosagem sólidas que contêm bactérias e vesículas extracelulares microbianas |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230355689A1 (https=) |
| EP (1) | EP4081195A1 (https=) |
| JP (1) | JP2023510158A (https=) |
| KR (1) | KR20220128362A (https=) |
| CN (1) | CN114945357A (https=) |
| AR (1) | AR122353A1 (https=) |
| AU (1) | AU2020413225A1 (https=) |
| BR (1) | BR112022012514A2 (https=) |
| CA (1) | CA3165418A1 (https=) |
| CO (1) | CO2022010242A2 (https=) |
| MX (1) | MX2022007943A (https=) |
| TW (1) | TW202135783A (https=) |
| WO (1) | WO2021133904A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021252861A1 (en) * | 2020-06-11 | 2021-12-16 | Evelo Biosciences, Inc. | Compositions and methods for treating diseases and disorders using megasphaera sp |
| EP4185307A1 (en) * | 2020-07-21 | 2023-05-31 | Evelo Biosciences, Inc. | Veillonella parvula strain as an oral therapy for neuroinflammatory diseases |
| KR20240093504A (ko) * | 2021-09-24 | 2024-06-24 | 에벨로 바이오사이언시즈, 인크. | 박테리아 및 미생물 세포외 소포를 함유하는 고체 투여 형태 |
| EP4429684A1 (en) * | 2021-12-16 | 2024-09-18 | Enterobiome Inc. | Pharmaceutical composition for preventing or treating cancer or inflammatory disease |
| CN115252651B (zh) * | 2022-06-08 | 2024-06-07 | 广州知易生物科技有限公司 | 嗜粘蛋白阿克曼菌在制备防治高血压的组合物中的应用和含有其的组合物 |
| JP2025530743A (ja) * | 2022-08-29 | 2025-09-17 | イーライ リリー アンド カンパニー | 経口投与のための組成物 |
| CN116509900B (zh) * | 2022-12-01 | 2023-11-10 | 佛山科学技术学院 | 益生菌或其细胞外囊泡在制备防治胃溃疡产品中的应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4775536A (en) | 1986-02-24 | 1988-10-04 | Bristol-Myers Company | Enteric coated tablet and process for making |
| US5292522A (en) | 1989-06-20 | 1994-03-08 | Rohm Gmbh | Aqueous film coating agent for solid medicaments |
| US5047258A (en) | 1989-07-14 | 1991-09-10 | Sterling Drug Inc. | Aqueous spray-coating process |
| US6623759B2 (en) | 1996-06-28 | 2003-09-23 | Astrazeneca Ab | Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof |
| DE19631084A1 (de) | 1996-08-01 | 1998-02-05 | Basf Ag | Verwendung von (Meth)acrylsäure-Copolymeren zur Erhöhung der Permeabilität der Schleimhaut |
| US6312728B1 (en) | 1998-07-07 | 2001-11-06 | Cascade Development, Inc. | Sustained release pharmaceutical preparation |
| DE69924735T2 (de) | 1998-07-28 | 2006-01-19 | Tanabe Seiyaku Co., Ltd. | Zur wirkstoffabgabe an zielorten im darm fähige zubereitung |
| DE19937361A1 (de) * | 1999-08-12 | 2001-02-22 | Merck Patent Gmbh | Orale Darreichungsform |
| US20040028737A1 (en) | 2002-08-12 | 2004-02-12 | Kopran Research Laboratories Limited | Enteric coated stable oral pharmaceutical composition of acid unstable drug and process for preparing the same |
| DE10260919A1 (de) | 2002-12-20 | 2004-07-01 | Röhm GmbH & Co. KG | Verfahren zur Herstellung von überzogenen Arzneiformen und Nahrungsergänzungsmitteln mit Konzentrationsgradienten im Überzug |
| EP1677770A2 (en) | 2003-10-31 | 2006-07-12 | Dexcel Ltd. | Stable lansoprazole formulation |
| US9149439B2 (en) | 2005-03-21 | 2015-10-06 | Sandoz Ag | Multi-particulate, modified-release composition |
| DE102005032806A1 (de) | 2005-07-12 | 2007-01-18 | Röhm Gmbh | Verwendung eines teilneutralisierten, anionischen (Meth)acrylat-Copolymers als Überzug für die Herstellung einer Arzneiform mit einer Wirkstofffreisetzung bei erniedrigten pH-Werten |
| CN101209247B (zh) * | 2006-12-27 | 2011-12-14 | 天津中新药业集团股份有限公司 | 一种结肠靶向制剂的制备方法 |
| CN101757042A (zh) * | 2009-05-25 | 2010-06-30 | 北京诚创康韵医药科技有限公司 | 一种益生菌微丸制剂及其制备 |
| SG11201503966PA (en) * | 2012-11-23 | 2015-06-29 | Seres Health Inc | Synergistic bacterial compositions and methods of production and use thereof |
| US8906668B2 (en) * | 2012-11-23 | 2014-12-09 | Seres Health, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
| MX357575B (es) | 2013-03-01 | 2018-07-16 | Bpsi Holdings Llc | Recubrimientos de pelicula de liberacion retardada que contienen silicato de calcio y sustratos recubiertos con los mismos. |
| AU2014239883B2 (en) * | 2013-03-14 | 2019-01-17 | Therabiome, Llc | Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents |
| WO2019152667A1 (en) * | 2018-01-31 | 2019-08-08 | Evelo Biosciences, Inc. | Compositions and methods for treating immune disorders using lachnospiraceae bacteria |
-
2020
- 2020-12-23 AR ARP200103650A patent/AR122353A1/es not_active Application Discontinuation
- 2020-12-23 MX MX2022007943A patent/MX2022007943A/es unknown
- 2020-12-23 BR BR112022012514A patent/BR112022012514A2/pt not_active Application Discontinuation
- 2020-12-23 JP JP2022539136A patent/JP2023510158A/ja active Pending
- 2020-12-23 KR KR1020227025604A patent/KR20220128362A/ko active Pending
- 2020-12-23 AU AU2020413225A patent/AU2020413225A1/en active Pending
- 2020-12-23 CN CN202080090020.6A patent/CN114945357A/zh active Pending
- 2020-12-23 CA CA3165418A patent/CA3165418A1/en active Pending
- 2020-12-23 US US17/789,427 patent/US20230355689A1/en active Pending
- 2020-12-23 WO PCT/US2020/066828 patent/WO2021133904A1/en not_active Ceased
- 2020-12-23 EP EP20853582.3A patent/EP4081195A1/en not_active Withdrawn
- 2020-12-25 TW TW109146331A patent/TW202135783A/zh unknown
-
2022
- 2022-07-19 CO CONC2022/0010242A patent/CO2022010242A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN114945357A (zh) | 2022-08-26 |
| KR20220128362A (ko) | 2022-09-20 |
| AR122353A1 (es) | 2022-09-07 |
| EP4081195A1 (en) | 2022-11-02 |
| TW202135783A (zh) | 2021-10-01 |
| WO2021133904A1 (en) | 2021-07-01 |
| CO2022010242A2 (es) | 2022-10-21 |
| CA3165418A1 (en) | 2021-07-01 |
| MX2022007943A (es) | 2022-07-27 |
| US20230355689A1 (en) | 2023-11-09 |
| JP2023510158A (ja) | 2023-03-13 |
| AU2020413225A1 (en) | 2022-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112022012514A2 (pt) | Formas de dosagem sólidas que contêm bactérias e vesículas extracelulares microbianas | |
| CL2020000075A1 (es) | Carboxamidas como moduladores de los canales de sodio. | |
| MX2023009527A (es) | Degradadores de la cinasa 4 asociada al receptor de interleucina 1 (irak4) y usos de los mismos. | |
| MX2022005132A (es) | Terapia combinada con formulaciones de anticuerpos anti-pvrig y anticuerpos anti-pd-1. | |
| BR112017017448A2 (pt) | métodos e composições para o tratamento de doença do olho ressecado e outros distúrbios do olho | |
| CO2022007814A2 (es) | Ligandos de la pseudoquinasa tyk2 | |
| MX2019014041A (es) | Inhibidores pirazolicos de magl. | |
| MX2019014042A (es) | Inhibidores pirazolicos de magl. | |
| BR112022000855A2 (pt) | Moduladores de nlrp3 | |
| MX2023001963A (es) | Composiciones farmaceuticas hipertonicas que contienen un agente quimioprotector antiplatino. | |
| BR112021019070A2 (pt) | Ligantes de pseudoquinase tyk2 | |
| CL2025003071A1 (es) | Formas cristalinas de inhibidores de ras, composiciones que las contienen y su uso. | |
| MX2025006782A (es) | Degradadores de la cinasa 4 asociada al receptor de interleucina-1 (irak4) y usos de los mismos | |
| CR20220322A (es) | Formulaciones de anticuerpos anti-pd-l1 | |
| BR112018015367A2 (pt) | carreadores oromucosais de nanofibra para tratamento terapêutico | |
| CO2022000270A2 (es) | Inhibidores de enzimas | |
| CY1122829T1 (el) | Φαρμακευτικη συνθεση για νευροπαθητικο πονο | |
| EA202290048A1 (ru) | Лекарственное средство и его применение для лечения бактериальных инфекций, связанных с биопленкой | |
| BR112021014566A2 (pt) | Moduladores de gpr35 | |
| MX392976B (es) | Composiciones que comprenden cepas bacterianas. | |
| CL2021003442A1 (es) | Composición farmacéutica que comprende idelalisib y defactinib; y métodos para el tratamiento de cáncer. | |
| BR112019001130A2 (pt) | uso de lactama e composição farmacêutica | |
| MX2021012146A (es) | Formulacion de tableta vaginal. | |
| CO2021000037A2 (es) | Métodos para modular los niveles de plasma de metabolitos de tetrabenazina utilizando bupropión | |
| PL431336A1 (pl) | Lipopeptydy, kompozycja farmaceutyczna, kompozycja kosmetyczna oraz lipopeptydy do zastosowania jako lek |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |